Study guide
16.1 Principles of Palliative & End-of-Life Nursing Care
Singapore Nursing Board SNB
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Legal Framework & Regulatory Governing of Nursing in Singapore
1.1 Nurses and Midwives Act & SNB Regulatory Powers 1.2 Scope of Professional Nursing Practice & Accountability 1.3 Informed Consent, Confidentiality & PDPA in Healthcare
2 Chapter 2: Ethical Standards & Professional Code of Conduct
2.1 SNB Code for Nurses and Midwives & Ethical Principles 2.2 Patient Rights, Advocacy & End-of-Life Ethical Decision-Making 2.3 Safeguarding Vulnerable Patients & Mandatory Reporting
3 Chapter 3: Holistic Patient Assessment & Nursing Process
3.1 Comprehensive Physical Assessment & Vital Signs Monitoring 3.2 Early Warning Scores & Recognising the Deteriorating Patient 3.3 Nursing Diagnosis, Person-Centred Care Planning & Evaluation
4 Chapter 4: Communication, Documentation & Clinical Safety
4.1 Therapeutic Communication & Interpersonal Care Relationships 4.2 Clinical Documentation Standards & ISBAR Clinical Handover 4.3 Clinical Risk Management, Fall Prevention & Patient Safety Goals
5 Chapter 5: Infection Prevention & Control Standards
5.1 Standard & Transmission-Based Precautions (Infection Control) 5.2 Aseptic Technique, Surgical Hand Antisepsis & Wound Care Asepsis 5.3 Outbreak Management, Multi-Drug Resistant Organisms (MDROs) & Bio-waste
6 Chapter 6: Safe Medication Administration & Clinical Pharmacology
6.1 Rights of Medication Administration & High-Alert Medications 6.2 Dosage Calculations, Unit Conversions & Pediatric/Geriatric Adjustments 6.3 Pharmacokinetics, Adverse Drug Reactions & Poison Management 6.4 Medication Reconciliation, Storage & Controlled Substances Act in SG
7 Chapter 7: Intravenous Therapy, Fluid & Electrolyte Management
7.1 Fluid Balance, Electrolyte Disturbances & ABG Interpretation 7.2 Peripheral & Central Venous Line Access, Care & Complications 7.3 Blood Product Transfusion Standards, Safety & Adverse Reaction Management
8 Chapter 8: Respiratory Care & Oxygenation Management
8.1 Airway Management, Oxygen Therapy & Pulse Oximetry 8.2 Tracheostomy Care, Suctioning & Mechanical Ventilation Nursing 8.3 Nursing Care in Acute Respiratory Distress & Chronic Obstructive Pulmonary Disease
9 Chapter 9: Cardiovascular Nursing & Hemodynamic Monitoring
9.1 Cardiac Assessment, ECG Interpretation & Common Arrhythmias 9.2 Acute Coronary Syndrome, Heart Failure & Hypertensive Crises Nursing 9.3 Shock Classification, Fluid Resuscitation & Hemodynamic Monitoring
10 Chapter 10: Medical-Surgical Nursing: Gastrointestinal & Renal Systems
10.1 Enteral & Parenteral Nutrition Management 10.2 Care of Acute Abdomen, Ostomy Care & Gastrointestinal Bleeding 10.3 Acute Kidney Injury, Chronic Kidney Disease & Dialysis Nursing
11 Chapter 11: Endocrine & Metabolic Nursing Management
11.1 Diabetes Mellitus: Glycemic Control, Insulin Therapy & Complications 11.2 Management of Diabetic Ketoacidosis (DKA) & Hyperosmolar Hyperglycemic State (HHS) 11.3 Thyroid, Adrenal & Pituitary Endocrine Disorders
12 Chapter 12: Neurological Nursing & Musculoskeletal Care
12.1 Neurological Assessment, Glasgow Coma Scale (GCS) & Stroke Care 12.2 Increased Intracranial Pressure (ICP) & Seizure Management 12.3 Musculoskeletal Assessment, Traction, Cast Care & Mobility Promotion
13 Chapter 13: Perioperative & Wound Management
13.1 Preoperative Assessment, Preparation & Informed Consent Verification 13.2 Intraoperative Standards, Surgical Time-Out & Anesthesia Monitoring 13.3 Postoperative Recovery, Pain Management & Wound Healing Staging
14 Chapter 14: Elder Care, Gerontological Nursing & Chronic Disease
14.1 Comprehensive Geriatric Assessment & Frailty Syndromes 14.2 Dementia, Delirium & Depression in Older Adults 14.3 Pressure Injury Prevention, Staging & Advanced Wound Dressings
15 Chapter 15: Mental Health Nursing & Psychosocial Care
15.1 Mental Health Assessment & Therapeutic Nurse-Patient Engagement 15.2 Mood Disorders, Psychosis & Crisis Intervention 15.3 Mental Health Act in Singapore, De-escalation & Patient Safety
16 Chapter 16: Palliative Care & Symptom Management
16.1 Principles of Palliative & End-of-Life Nursing Care 16.2 Pain Assessment, Opioid Titration & Breakthrough Pain Management 16.3 Advance Care Planning (ACP) & Care of the Dying Patient
17 Chapter 17: Interprofessional Collaboration & Care Coordination
17.1 Transdisciplinary Team Dynamics & Multidisciplinary Case Conferences 17.2 Care Coordination, Community Discharge Planning & Continuity of Care 17.3 Conflict Resolution & Interprofessional Communication
18 Chapter 18: Delegation, Supervision & Clinical Leadership
18.1 Principles of Delegation to Enrolled Nurses (ENs) & Ancillary Staff 18.2 Clinical Supervision, Resource Management & Ward Operations 18.3 Quality Improvement, Clinical Audit & Incident Reporting
19 Chapter 19: Evidence-Based Practice, Education & Professional Growth
19.1 Reflective Practice & SNB CPE (Continuing Professional Education) Requirements 19.2 Integrating Evidence-Based Practice (EBP) into Clinical Care 19.3 Clinical Education, Student Preceptorship & Mentorship
16.1 Principles of Palliative & End-of-Life Nursing Care
Key Takeaways Explain This Topic AI
Palliative care addresses physical, psychological, social and spiritual suffering in life-limiting illness and can accompany active disease treatment.
Breathlessness needs assessment of causes and comfort measures; prescribed opioids may help selected patients, with route-, organ-function- and exposure-specific dosing and monitoring.
Oxygen is not routine treatment for every non-hypoxaemic breathless person; use the actual clinical and goals-of-care plan rather than a universal saturation cutoff.
Noisy secretions require comfort assessment, explanation, positioning/oral care and selected prescribed treatment; they do not establish an exact time to death or prove absence of distress.
Proportionate symptom relief, consent and monitoring differ from intentional life-ending acts. Double effect is an ethical concept, not automatic legal immunity.
Last updated: October 2026
- 16.1 Principles of Palliative & End-of-Life Nursing Care
- Palliative care begins with needs and goals
Palliative care supports people with life-limiting illness and those important to them through relief of physical, psychological, social and spiritual suffering. It is not restricted to cancer, the last hours of life or the point when every disease-directed treatment has failed. It can be provided alongside active treatment, with the balance reviewed as the illness and the person’s priorities change.
Singapore care can involve hospital teams, community/home services, day services and inpatient hospice arrangements. The appropriate setting depends on needs, preferences, caregiver capacity, service availability and accepted referrals. A referral or a preferred place of care is not a guarantee of admission, home staffing or a fixed prognosis threshold.
SNB Code, April 2018 , supports dignity, autonomy, competence, advocacy and collaboration. Assess symptoms, the person’s understanding and preferences, communication needs, functional status, medicines and support. Agree a plan with the responsible team, document what matters to the person and review response rather than treating one checklist as a permanent decision.
Team and family support
Nurses contribute ongoing assessment, comfort care, medicine verification, symptom monitoring, education and coordination. Medical/palliative clinicians assess causes and prescribe the treatment plan. Pharmacy, rehabilitation, social work and spiritual-care professionals can address additional needs. Involve chosen supporters appropriately while respecting capacity, consent and confidentiality; do not assume every family wants or can provide the same care.
Explain expected changes in clear language, check understanding and offer practical guidance about whom to contact. Address caregiver exhaustion, grief, finances and the feasibility of the care setting. Ask about religious, cultural and personal practices rather than assuming them from a label. Bereavement support can begin before death and continue afterwards according to needs and available services.
Breathlessness: symptom and cause
Assess the person’s experience, onset, severity, associated signs, possible reversible causes and the agreed goals. Hypoxia, infection, fluid overload, bronchospasm, anaemia, anxiety and other causes may need different responses. A saturation display does not quantify the full burden of breathlessness, and a normal reading does not exclude important illness.
Positioning for comfort, calm support, a suitable fan/airflow and practical pacing may help when appropriate. Treat reversible causes where consistent with the person’s plan. Singapore’s National Guidelines for Safe Prescribing of Opioids 2021 describe assessing causes, optimising disease treatment and considering opioids for appropriate breathlessness in people approaching the end of life. This does not establish one dose for every patient.
The prescription must account for prior opioid exposure, route/formulation, renal/liver function, other sedatives and response. Oral and subcutaneous morphine doses are not automatically interchangeable. Do not offer the same generic “2.5–5 mg orally or subcutaneously” instruction to everyone. Monitor benefit, sedation, breathing and other adverse effects, and seek specialist help when response or safety is uncertain.
Appropriate titration does not create a guarantee that respiratory depression cannot occur. Conversely, breathlessness alone does not prove opioid toxicity. Naloxone is not categorically contraindicated in palliative care : suspected clinically significant opioid toxicity requires urgent assessment and the appropriate reversal/support plan, considering dependence and symptom control. Do not give or withhold an antidote solely from a blanket label.
Oxygen is not routinely helpful for every non-hypoxaemic breathless person. Assess possible hypoxaemia, clinical benefit, burden and the individual treatment goals. NICE NG31 , a named UK last-days-of-life reference, advises against routinely starting oxygen for breathlessness without known or clinically suspected symptomatic hypoxaemia. It is not a universal Singapore rule that oxygen is permitted only below one SpO₂ value. Follow the actual patient’s plan and reassess.
Noisy respiratory secretions
Reduced ability to clear secretions can cause noisy breathing near the end of life. Explain the likely mechanism and assess signs of discomfort and other causes. The sound can distress relatives, but do not promise that the patient can never be distressed or that the noise predicts death within exactly 24–48 hours.
Offer gentle mouth care and positioning as appropriate to comfort and safety. Avoid routine deep/invasive suctioning when its burdens outweigh benefit; seek the appropriate team’s advice for a specific obstruction or another treatable cause. Review fluid/medicine factors within the plan rather than automatically stopping all hydration or treating every sound as infection.
A prescribed antimuscarinic may reduce further secretion production; it does not simply remove all already pooled secretions. Agent selection, route and monitoring depend on the person and local formulary. Watch for dry mouth, urinary retention, delirium, sedation and other adverse effects. Do not copy a foreign fixed-dose regimen into a Singapore bedside order.
Nausea, delirium and other symptoms
Symptom Assessment and supportive care Prescription safeguards
Nausea/vomiting Assess medicines, constipation, obstruction, metabolic and other causes; provide comfort/oral care and appropriate intake support Select an antiemetic for the likely cause. Metoclopramide, haloperidol, cyclizine or other agents are not universally interchangeable; obstruction, neurological and cardiac risks matter
Agitation/delirium Assess pain, urinary retention/constipation, medication effects, infection, metabolic causes and environment; support orientation and calm A benzodiazepine or antipsychotic may be selected for a defined indication. Do not make haloperidol first-line for every patient; Parkinsonism, Lewy-body dementia, QT risk and unwanted sedation require particular caution
Pain Assess intensity, cause, pattern, previous treatment and the person’s goals; combine appropriate non-drug and drug approaches Verify opioid/non-opioid choice, route, dose, breakthrough plan, bowel/adverse-effect management and monitoring
Refractory distress Reassess causes and burdens, involve experienced palliative clinicians and the patient/appropriate decision process Proportionate sedation, when considered, requires a defined indication, consent/authority, prescription, monitoring and review—not a routine response to staff workload
The purpose is individual symptom relief, not suppression of every behaviour or a guarantee that one medicine will work. If the diagnosis, response or adverse effects are uncertain, seek specialist review. Advance/anticipatory prescriptions still require assessment of the actual current symptom before administration and an appropriate route; the existence of a PRN order is not a requirement to give it automatically.
Legal and ethical distinctions
Support voluntary, informed choices and assess capacity for the actual decision. A capable refusal of a treatment is not itself proof of incapacity. Where capacity is lacking, use the appropriate lawful best-interests/authorised decision process, with attention to the person’s wishes and applicable limits.
Advance Care Planning (ACP) is a process of discussing values and future care preferences; Singapore’s public information describes those conversations as voluntary and non-legally binding. An Advance Medical Directive (AMD) is a separate statutory instrument with defined conditions. Neither a general conversation nor a “do not attempt resuscitation” decision means that all comfort, nursing or appropriate treatment stops.
Singapore’s AMD Act section 11 preserves palliative care, and section 17 does not authorise euthanasia or abetment of suicide. Do not equate lawful limitation of burdensome treatment, proportionate symptom relief and intentional life-ending acts.
The doctrine of double effect is an ethical way of considering intended benefit, foreseeable harm, proportionality and alternatives. It is not automatic legal immunity for any dose escalation or sedation. Care still requires a valid clinical indication, appropriate consent/authority, competence, prescription and monitoring. Never intentionally escalate medicines to cause death under the label of comfort care.
Primary reading
MOH palliative-care information , Singapore’s opioid guideline, April 2021 , NICE NG31 as an explicitly named UK symptom-care reference, Singapore AMD Act , ACP information , and SNB Code . No universal drug regimen or guaranteed prognosis is implied.